Condition: Anal Cancer · Quality of Life · Chemoradiation · Sponsor: Ludwig-Maximilians - University of Munich
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer
This description comes directly from the study's public registry record.
Falk Roeder, MD · +49894400 · falk.roeder@t-online.de
Sabine Gerum, MD · +49894400 · sabine.gerum@med.uni-muenchen.de
Always discuss trial participation with your own doctor first.
| Department of Radiation Oncology, University Hospital, LMU Munich | Munich, Bavaria, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03792854